IRIS
DE ROSA, ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.703
NA - Nord America 4.559
EU - Europa 3.529
SA - Sud America 552
Continente sconosciuto - Info sul continente non disponibili 297
AF - Africa 134
OC - Oceania 7
Totale 13.781
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.380
SG - Singapore 1.991
RU - Federazione Russa 1.510
VN - Vietnam 977
CN - Cina 864
IT - Italia 749
BR - Brasile 440
HK - Hong Kong 347
DE - Germania 269
FI - Finlandia 194
NL - Olanda 181
FR - Francia 166
CA - Canada 105
BD - Bangladesh 96
GB - Regno Unito 94
IN - India 89
IE - Irlanda 88
JP - Giappone 72
UA - Ucraina 67
SE - Svezia 45
MX - Messico 43
CI - Costa d'Avorio 38
AR - Argentina 37
PH - Filippine 37
KR - Corea 34
ZA - Sudafrica 32
PL - Polonia 28
IQ - Iraq 27
ES - Italia 25
TW - Taiwan 22
BG - Bulgaria 19
TR - Turchia 16
CO - Colombia 15
AT - Austria 14
MA - Marocco 14
ID - Indonesia 13
LT - Lituania 13
PY - Paraguay 13
TH - Thailandia 13
CL - Cile 12
EC - Ecuador 12
JO - Giordania 12
MK - Macedonia 11
PK - Pakistan 11
SA - Arabia Saudita 10
UZ - Uzbekistan 10
VE - Venezuela 10
BE - Belgio 9
EG - Egitto 8
KE - Kenya 8
MY - Malesia 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
KZ - Kazakistan 7
NP - Nepal 7
RS - Serbia 7
CR - Costa Rica 6
IL - Israele 6
IR - Iran 6
JM - Giamaica 6
UY - Uruguay 6
CH - Svizzera 5
DZ - Algeria 5
PE - Perù 5
DO - Repubblica Dominicana 4
EE - Estonia 4
LB - Libano 4
MU - Mauritius 4
AU - Australia 3
ET - Etiopia 3
GE - Georgia 3
GR - Grecia 3
MT - Malta 3
NG - Nigeria 3
PS - Palestinian Territory 3
SN - Senegal 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CG - Congo 2
CY - Cipro 2
DK - Danimarca 2
GA - Gabon 2
GN - Guinea 2
HR - Croazia 2
KW - Kuwait 2
NI - Nicaragua 2
NO - Norvegia 2
NR - Nauru 2
OM - Oman 2
PR - Porto Rico 2
RO - Romania 2
AD - Andorra 1
AL - Albania 1
AO - Angola 1
AP - ???statistics.table.value.countryCode.AP??? 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CV - Capo Verde 1
Totale 13.458
Salva come PNG Salva come JPEG
Città #
Singapore 936
San Jose 857
Chandler 445
Ashburn 398
Moscow 341
Hong Kong 322
Beijing 293
Ho Chi Minh City 279
Hanoi 212
Santa Clara 173
Munich 160
Amsterdam 150
Hefei 133
Naples 109
Lauterbourg 106
Los Angeles 106
Dallas 90
Millbury 88
Helsinki 86
The Dalles 80
Napoli 76
Princeton 65
Nanjing 64
Columbus 57
New York 57
Tokyo 57
Des Moines 55
Boston 47
Buffalo 43
Redondo Beach 42
Orem 40
Seattle 40
Turku 40
Da Nang 38
São Paulo 37
Haiphong 33
Council Bluffs 31
Ottawa 31
Chicago 30
Milan 29
Lawrence 26
Montreal 26
Norwalk 25
Wilmington 25
London 24
Rome 24
Seoul 23
Frankfurt am Main 21
Houston 21
Denver 20
Jacksonville 20
Toronto 20
Warsaw 20
Mexico City 19
Nuremberg 19
Biên Hòa 18
Brooklyn 18
Pune 17
Atlanta 16
Chennai 16
Dong Ket 16
Sofia 14
Belo Horizonte 13
Hebei 13
Hải Dương 13
Phoenix 13
Shenyang 13
Stockholm 13
Washington 13
Bari 12
Poplar 12
Redwood City 12
San Francisco 12
Amman 11
Can Tho 11
Dearborn 11
Dhaka 11
Nanchang 11
Falkenstein 10
Goiânia 10
Jiaxing 10
Johannesburg 10
Baghdad 9
Changsha 9
Charlotte 9
Dublin 9
Asunción 8
Bangkok 8
Gricignano di Aversa 8
Manchester 8
Nola 8
Paris 8
Shanghai 8
Tashkent 8
Thái Nguyên 8
Augusta 7
Bauru 7
Brasília 7
Brussels 7
Fairfield 7
Totale 7.101
Salva come PNG Salva come JPEG
Nome #
A case of restless leg syndrome in a family with LRRK2 gene mutation. 290
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 208
Alteration of endosomal trafficking is associated with neurodegenerative diseases 202
Assessment of non-motor and autonomic symptoms in Wilson's disease patients 198
GBA-Related Parkinson’s Disease:Dissection of Genotype–Phenotype Correlates in a LargeItalian Cohort 174
Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression 166
Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis 165
Prevalence and features of headache in Parkinson's disease: the role of dopamine 163
Parkinsonism in adult-onset Rasmussens's encephalitis: a clinical picture presenting as corticobasal syndrome 163
Non-motor symptoms and cardiac innervation in SYNJ1-related parkinsonism 163
Reproductive function of long-term treated patients with hepatic onset of Wilson's disease: a prospective study 161
Prevalence and features of non-motor symptoms in Wilson's disease 159
Emotion Recognition and Psychological Comorbidity in Friedreich’s Ataxia 158
The Heterogeneity of Early Parkinson?s Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients 156
Long-term effect of epoetin alfa on clinical and biochemical markers in friedreich ataxia 156
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 155
Screening for Fabry disease in a series of Parkinson’s disease patients and literature review 154
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients. 154
Long-term therapy with miglustat and cognitive decline in the adult form of Niemann-Pick disease type C: a case report 154
Pathological laughter as onset symptom in atypical parkinsonisms 153
Motor and non-motor features in Parkinson's Disease patients carrying GBA gene mutations 151
CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients 146
Frontal defect contribution to decreasing of body mass index in Parkinson's disease patients 145
Impulsive-compulsive behaviors in parkin-associated Parkinson disease 144
PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism. 144
Chorea-acanthocytosis without chorea: Expanding the clinical phenotype 144
Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a 144
Autonomic disorders and myocardial 123I-metaiodobenzylguanidine scintigraphy in Huntington's disease 144
Animal-Assisted Therapy in Elderly Patients: Evidence and Controversies in Dementia and Psychiatric Disorders and Future Perspectives in Other Neurological Diseases 142
Lamivudine and fingolimod co-administration in two patients with multiple sclerosis and occult hepatitis B virus infection 141
Cutaneous sensory and autonomic denervation in Progressive Supranuclear Palsy 141
Peripheral markers of autophagy in polyglutamine diseases 139
Application of the p9NORM correction method to timed neuropsychological tests in Parkinson's disease and multiple system atrophy. 139
Myocardial (123)I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations 137
MRI analysis of two cases of cerebrotendinous xanthomathosis (Studio RM di due casi di xantomatosi cerebro-tendinea) 136
The flavor test is a sensitive tool in identifying the flavor sensorineural dysfunction in Parkinson's disease 136
Brain Susceptibility Changes in a Patient with Natalizumab-Related Progressive Multifocal Leukoencephalopathy: A Longitudinal Quantitative Susceptibility Mapping and Relaxometry Study 136
Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. 135
Stability of erythropoietin repackaging in polypropylene syringes for clinical use 134
Introversion and Neuroticism in Akinetic-Rigid Parkinson’s Disease: Association With Frontal-Executive Dysfunction 133
Cognitive profile and 18F-fluorodeoxyglucose PET study in LRRK2-related Parkinson's disease 133
Genetic screening for LRRK2 gene G2019S mutation in Parkinson's disease patients from Southern Italy. 133
Mobitz type I and II atrioventricular blocks during fingolimod therapy 133
Efficacy of dopamine agonist treatment in delayed-onset parkinsonism due to midbrain hemorrhage. 131
Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17 128
The Italian tremor Network (TITAN): rationale, design and preliminary findings. 128
Clinical trial eligibility in PSP: Population representativeness and potential criteria adjustment based on PSP-NET findings 126
Screening for dopa-responsive dystonia in patients with scans without evidence of dopaminergic deficiency (SWEDD). 126
Othello syndrome in Parkinson's disease: a systematic review and report of a case series 126
A novel mutation in GCH-1 gene in a case of dopa-responsive dystonia. 124
Conventional MRI findings in hereditary degenerative ataxias: a pictorial review 124
Constructional Apraxia is related to Different Cognitive Defect's across Dementia 123
Novel human pathological mutations. Gene symbol: NOTCH3. Disease: CADASIL. 122
Co-existence of primary hyperparathyroidism and Parkinson's disease in three patients: an incidental finding? 121
Genetic Screening for the LRRK2 R1441C and G2019S Mutations in Parkinsonian Patients from Campania. 120
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 120
Antiphospholipid-related chorea. 119
Olfactory function and cognition in relapsing–remitting and secondary-progressive multiple sclerosis 119
Screening for RFC-1 pathological expansion in late-onset ataxias: a contribution to the differential diagnosis. 119
Postganglionic sudomotor denervation in patients with multiple system atrophy 118
The magnetic apraxia of Denny-Brown 118
Normalization of timed neuropsychological tests with the PATA rate and nine-hole pegboard tests 117
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 116
Infusion treatments and deep brain stimulation in Parkinson's Disease: The role of nursing 116
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease 116
Gender differences in non-motor symptoms in early, drug naive Parkinson's disease 115
XR-Based Serious Game for Assessing Bradykinesia in Patients with Parkinson’s Disease 114
Dissociative Identity Disorder: Restoration of Executive Functions After Switch from Alter to Host Personality. 114
Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort. 113
A longitudinal real-life comparison study of natalizumab and fingolimod 113
Novel human pathological mutations. Gene symbol: NOTCH3. Disease: CADASIL. 112
Psychometric properties and clinical correlates of the Frontal Behaviour Inventory in progressive supranuclear palsy: data from the PSP-NET 111
Comparing Essential Tremor with and without Soft Dystonic Signs and Tremor Combined with Dystonia: The TITAN Study 111
Suppression of myoclonus in SCA2 by piracetam. 110
Neurosyphilis with complex partial status epilepticus and mesiotemporal MRI abnormalities mimicking herpes simplex encephalitis 109
Ataxia and Hypogonadism: a Review of the Associated Genes and Syndromes. 108
Subacute combined degeneration of the spinal cord in a vegan. 108
Frequency and distribution of polyQ disease intermediate-length repeat alleles in healthy Italian population. 107
Parkinsonism may be part of the symptom complex of DOOR syndrome. 107
The LRRK2 R1441C mutation is more frequent than G2019S in Parkinson's disease patients from southern Italy. 106
Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study 106
Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease Project 105
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 104
Gender differences in microRNA expression in levodopa-naive PD patients 104
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s disease study 103
insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early,drug-naive Parkinson's disease. 103
Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized Patients With COVID-19 Infected With Pre-Omicron Variants 102
The importance of being persistent to multiple sclerosis treatments 102
Correction to: Peripheral markers of autophagy in polyglutamine diseases (Neurological Sciences, (2018), 39, 1, (149-152), 10.1007/s10072-017-3156-6) 102
Neurophysiological evaluation of motor corticospinal pathways by TMS in idiopathic early-onset Parkinson's disease. 100
Screening for Niemann-Pick type C disease in neurodegenerative diseases 99
Anti-CRMP5 paraneoplastic chorea: selective external capsule MRI involvement resolving after tumour resection 98
The Framingham cardiovascular risk score in multiple sclerosis 95
Validation of the Italian version of the PSP Quality of Life questionnaire 95
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 94
PERK-Mediated Unfolded Protein Response Activation and Oxidative Stress in PARK20 Fibroblasts 92
Autonomic nervous system abnormalities in spinocerebellar ataxia type 2: a cardiovascular neurophysiologic study. 90
Constructional Impairments and Their Neural Correlates in Nondemented Adults With Cerebral Autosomal-dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy 85
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 85
Spectral domain and angiography optical coherence tomography in atypical parkinsonisms and Parkinson disease: an explorative study 83
Totale 12.944
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.859
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.859
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022595 0 11 4 10 22 16 13 19 94 51 128 227
2022/20231.014 111 104 33 84 116 115 18 68 162 150 46 7
2023/2024628 32 90 71 53 52 66 34 88 9 11 80 42
2024/20253.472 145 103 23 45 129 174 515 234 248 310 1.262 284
2025/20266.693 688 453 716 629 1.085 282 865 370 787 491 152 175
2026/2027273 173 100 0 0 0 0 0 0 0 0 0 0
Totale 13.781